Market Tracker

10/24 4:17am ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

35.03
Data as of Oct 23
 +2.76 / +8.55%
Today’s Change
27.51
Today|||52-Week Range
39.95
+19.97%
Year-to-Date

Today’s Trading

Previous close32.27
Today’s open32.70
Day’s range-- - --
Volume1,131,111
Average volume (3 months)695,416
Market cap$1.3B
Dividend yield--
Data as of 10/23/2014

Growth & Valuation

Earnings growth (last year)-89.84%
Earnings growth (this year)-45.73%
Earnings growth (next 5 years)+45.00%
Revenue growth (last year)+10.01%
P/E ratio77.8
Price/Sales3.49
Price/Book3.00

Competitors

 Today’s
change
Today’s
% change
CBPOChina Biologic Produ...+0.01+0.02%
INSYInsys Therapeutics I...-0.31-0.80%
PDLIPDL BioPharma Inc+0.07+0.85%
GWPHGW Pharmaceuticals P...+1.32+1.84%
Data as of 10/23/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)$0.06
Annual revenue (last year)$336.4M
Annual profit (last year)$16.4M
Net profit margin4.89%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts